Cargando…
Neuroprotective properties of DPP‐4i: A therapeutic target for dementia prevention in elderly diabetic patients?
Possible mechanisms of Alzheimer's disease‐related cognitive impairment in patients with diabetes mellitus are shown in this figure. DPP‐4i may modulate Aβ accumulation in the process of AD‐related cognitive impairment.[Image: see text]
Autores principales: | Umemura, Toshitaka, Kawamura, Takahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034947/ https://www.ncbi.nlm.nih.gov/pubmed/36617734 http://dx.doi.org/10.1111/jdi.13972 |
Ejemplares similares
-
Is cognitive impairment the fourth diabetic microvascular complication?
por: Kawamura, Takahiko, et al.
Publicado: (2011) -
Retinopathy: A sign of cerebral small vessel disease in diabetes?
por: Umemura, Toshitaka, et al.
Publicado: (2017) -
Effect of diabetes on stroke symptoms and mortality: Lessons from a recent large population‐based cohort study
por: Umemura, Toshitaka, et al.
Publicado: (2014) -
Curious relationship between cognitive impairment and diabetic retinopathy
por: Kawamura, Takahiko, et al.
Publicado: (2015) -
Are the polyol pathway and hyperuricemia partners in the development of non‐alcoholic fatty liver disease in diabetes?
por: Hotta, Nigishi, et al.
Publicado: (2020)